NIRMALTRELVIR

Nirmaltrelvir is a SARSCoV2 protease inhibitor used with ritonavir to block viral replication. Side effects include altered taste, diarrhea, hypertension, and druginteraction risks. Only GMP materials will be supplied, logistics all according to GDP.

Product Description


Mechanism of Action

NIRMALTRELVIR exhibits a high-dimensional biochemical activity profile integrating catalyticdomain modulation, multiaxis signalling disruption, mitochondrialnetwork recalibration, ionflux redistribution, redoxstate restructuring, cytoskeletal remodelling, membraneelectrochemical modulation and transcriptionfactor pathway reprogramming. Its molecular architecture supports highaffinity interaction with catalytic residues, allosteric regulators, hydrophobic receptor pockets, transmembrane helices, nucleotidebinding pockets, redoxbuffer matrices and polymeric scaffolding complexesgranting broad mechanistic influence across metabolic, genomic, electrophysiological and structural systems.

NIRMALTRELVIR may reorganise phosphorylationflow geometry across ERK/MAPK/JNK/p38 cascades, alter PI3KAKT survival signalling, shift Gprotein coupling patterns, redistribute Ca²⁺ microdomains, reshape IP/DAG signalling topology, and recalibrate cAMPPKA amplitude dynamics. Mitochondrial impacts include ETCcomplex activation shifts, ATP/ADP turnover modulation, ROSthreshold displacement, mitochondrialmembrane potential polarity changes and ERmitochondrial stresssignal coupling, making the compound highly valuable for mechanistic and translational research models.

Advanced

  • Kinomescale catalyticcascade mapping and interference modelling
  • Ultraresolution ligand docking and conformationaltransition analysis
  • UPR/ERstress, mitophagy, autophagy and oxidativestress crossnetwork characterisation
  • Multiomics system reconstruction (RNAseq, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal mechanics and polymerturnover modelling
  • Cellfate mapping across apoptosis, necroptosis, ferroptosis, pyroptosis and parthanatos
  • Machinelearning driven SAR/QSAR molecularperformance prediction

Toxicodynamics & Cellular Hazard Spectrum

  • ROS hyperaccumulation and antioxidant-system collapse
  • Mitochondrial fragmentation, ETC shutdown or hyperleak states
  • Severe Na⁺/K⁺/Ca²⁺ ionic-flux dysregulation
  • Cytoskeletal depolymerisation and membrane-integrity failure
  • NF-κB, STAT and IRF inflammatoryaxis hyperactivation
  • Engagement of multiaxis programmed-cell-death pathways
  • Epigenetic drift including methylation and acetylation imbalance

For expert laboratory research only not intended for biological or therapeutic exposure.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C23H32F3N5O4

Molecular Weight

499.5 g/mol

CAS Number

2628280-40-8

Storage Condition

Store at 28°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

Nirmatrelvir; 2628280-40-8; PF-07321332; Paxlovid; PF07321332

IUPAC/Chemical Name

(1R,2S,5S)-N-((1S)-1-cyano-2-((3,3-difluorocyclopropyl)amino)-2-oxoethyl)-3,3-difluoro-5-(trifluoromethyl)pyrrolidine-1-carboxamide

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download